Cargando…
Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5
Cancer cells undergo a shift in metabolism where they become reliant on nutrients such as the amino-acid glutamine. Glutamine enters the cell via the alanine/serine/cysteine transporter 2 (ASCT2) that is upregulated in several cancers to maintain an increased supply of this nutrient and are therefor...
Autores principales: | Scopelliti, Amanda J, Font, Josep, Vandenberg, Robert J, Boudker, Olga, Ryan, Renae M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750217/ https://www.ncbi.nlm.nih.gov/pubmed/29295993 http://dx.doi.org/10.1038/s41467-017-02444-w |
Ejemplares similares
-
Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
por: Yu, Xiaodi, et al.
Publicado: (2019) -
The archaeal glutamate transporter homologue Glt(Ph) shows heterogeneous substrate binding
por: Reddy, Krishna D., et al.
Publicado: (2022) -
Characterizing unexpected interactions of a glutamine transporter inhibitor with members of the SLC1A transporter family
por: Freidman, Natasha J., et al.
Publicado: (2022) -
Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2018) -
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)